Cian Healthcare Ltd vs Iol Chemicals Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Cian Healthcare Ltd is ₹ 8.26 as of 10 Apr 15:30 . The P/E Ratio of Cian Healthcare Ltd changed from 34.6 on March 2023 to 562.5 on March 2021 . This represents a CAGR of 100.80% over 4 yearsThe P/E Ratio of IOL Chemicals & Pharmaceuticals Ltd changed from 12.4 on March 2022 to 0 on March 2021 . This represents a CAGR of -100.00% over 5 years The Market Cap of Cian Healthcare Ltd changed from ₹ 47.62 crore on March 2022 to ₹ 26.28 crore on March 2021 . This represents a CAGR of -11.21% over 5 yearsThe Market Cap of IOL Chemicals & Pharmaceuticals Ltd changed from ₹ 2077 crore on March 2022 to ₹ 0 crore on March 2021 . This represents a CAGR of -100.00% over 5 years The revenue of Cian Healthcare Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of IOL Chemicals & Pharmaceuticals Ltd for the Dec '25 is ₹ 585.68 crore as compare to the Sep '25 revenue of ₹ 574.41 crore. This represent the growth of 1.96% The ebitda of Cian Healthcare Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of IOL Chemicals & Pharmaceuticals Ltd for the Dec '25 is ₹ 51.36 crore as compare to the Sep '25 ebitda of ₹ 63.96 crore. This represent the decline of -19.7% The net profit of Cian Healthcare Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of IOL Chemicals & Pharmaceuticals Ltd changed from ₹ 29.97 crore to ₹ 20.58 crore over 7 quarters. This represents a CAGR of -19.33% The Dividend Payout of Cian Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of IOL Chemicals & Pharmaceuticals Ltd changed from 7.92 % on March 2021 to 23.25 % on March 2025 . This represents a CAGR of 24.03% over 5 years .

About Cian Healthcare Ltd

Cian Healthcare Limited was originally incorporated as a Private Limited Company with the name of 'Cian Healthcare Private Limited' on January 07, 2003.
Subsequently, the Company was converted into a Public Limited Company and the name of the Company was changed to 'Cian Healthcare Limited' pursuant to a fresh Certificate of Incorporation granted by the Registrar of Companies, Pune dated November 30, 2018. The Company is a certified transnational manufacturing Company with wide range of Pharmaceutical, Nutraceutical, Ayurvedic, Cosmeceuticals, Sexual Wellness and Food supplement products.
The Company complies with the standard manufacturing practices as laid down by the World Health Organization and is also certified by the Food and Drug Control Administration. The Company started manufacturing unit at Roorkee in Uttarakhand in 2013.

About IOL Chemicals & Pharmaceuticals Ltd

IOL Chemicals and Pharmaceuticals Limited, incorporated in September, 1986 is a renowned company in the Active Pharmaceutical Ingredient (API) and specialty chemicals sectors.
Its extensive expertise in both API and specialty chemicals strengthens the business model and opens doors to diversified growth opportunities. Within the API segment, IOL develops and supplies a wide range of essential products utilized by pharmaceutical companies worldwide for the production of key medicines.
It serves as a global supplier of various APIs, including Ibuprofen, Metformin, Clopidogrel, Lamotrigine, Pantoprazole, and Fenofibrate, alongside other APIs, and maintains a significant presence in all major therapeutic categories. In the Specialty Chemicals division, IOL manufactures Ethyl Acetate, Iso Butyl Benzene (IBB), Mono Chloro Acetic Acid (MCA), and Acetyl Chloride.

FAQs for the comparison of Cian Healthcare Ltd and IOL Chemicals & Pharmaceuticals Ltd

Which company has a larger market capitalization, Cian Healthcare Ltd or IOL Chemicals & Pharmaceuticals Ltd?

Market cap of Cian Healthcare Ltd is 20 Cr while Market cap of IOL Chemicals & Pharmaceuticals Ltd is 3,177 Cr

What are the key factors driving the stock performance of Cian Healthcare Ltd and IOL Chemicals & Pharmaceuticals Ltd?

The stock performance of Cian Healthcare Ltd and IOL Chemicals & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Cian Healthcare Ltd and IOL Chemicals & Pharmaceuticals Ltd?

As of May 18, 2026, the Cian Healthcare Ltd stock price is INR ₹8.26. On the other hand, IOL Chemicals & Pharmaceuticals Ltd stock price is INR ₹108.24.

How do dividend payouts of Cian Healthcare Ltd and IOL Chemicals & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Cian Healthcare Ltd and IOL Chemicals & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.